PIK3CA H1047L
|
HER2 Positive Breast Cancer
|
PIK3CA H1047L
|
HER2 Positive Breast Cancer
|
PF-05212384 + Herzuma (trastuzumab biosimilar) Sensitive: C3 – Early Trials
|
PF-05212384 + Herzuma (trastuzumab biosimilar) Sensitive: C3 – Early Trials
|
PIK3CA H1047L
|
Breast Cancer
|
PIK3CA H1047L
|
Breast Cancer
|
GDC-0941 Sensitive: D – Preclinical
|
GDC-0941 Sensitive: D – Preclinical
|
PIK3CA H1047L
|
Oral Cancer
|
PIK3CA H1047L
|
Oral Cancer
|
palbociclib Resistant: D – Preclinical
|
palbociclib Resistant: D – Preclinical
|